Confidence among higher-income consumers is rising, boosting their desire to spend on premium airline tickets, luxury goods, and everything in between. Retailers are rushing to premiumize, targeting higher-income households with the means and willingness to spend. But these shoppers are discriminating: Companies looking to earn their spending must deliver products and experiences that meet their high standards—and prepare for the possibility of buyer’s remorse.

Open banking and its uncertain future in the US dominated discussions across FinovateFall’s 2025 agenda. Financial institutions (FIs) that already offer open banking capabilities—and those finding new ways to use open banking—will have a competitive advantage over those waiting for more clarity. It’s important to remember who owns the data in question—the customers. And the ultimate question FIs should be asking themselves is: How can they leverage that data to provide the best experience possible for their customers? While it’s unlikely that next steps will include fee-less transfer of this data, FIs must consider how their next steps into open banking can set them apart from the competition. For now, the most obvious step is letting customers manage which parties can access their data.

Kroger raised its full-year core sales outlook for the second time in 2025, now expecting same-store sales growth of 2.7% to 3.4%, as demand for low-cost essentials remains strong among budget-conscious shoppers. The grocer’s Q2 results topped expectations for comparable sales and earnings, supported by growth in fresh food, ecommerce, and pharmacy, though total revenue narrowly missed analyst estimates. Following the collapse of its Albertsons merger, Kroger has prioritized profitability through store closures, job cuts, and online margin improvements while doubling down on private labels, promotions, and value-driven initiatives to defend market share against discount rivals like Aldi, Lidl, and Trader Joe’s.

Hims & Hers is expanding into a new men's health category by offering treatments for low testosterone. But it will need to navigate strict FDA oversight. The FDA has previously warned companies against exaggerated claims, stating that these treatments are only approved for men with low testosterone caused by specific medical conditions—not for general symptoms like fatigue from normal aging. Marketers must educate consumers on the FDA-approved status of their products, make it clear that a blood test will determine eligibility for a subscription, and avoid generalized messaging about the treatments' benefits for low energy or tiredness.

Oracle’s new AI portal, built on OpenAI’s technology, will let patients ask questions and get plain-language explanations about test results, diagnoses, and treatment options. Oracle understands patients are already using AI to interpret health records, so offering a safer, private way to do so is a smart move. Healthtech providers need to ensure AI tools for patients are highly accurate and offer clear guidance to users on how to use the tools, what the limits are, and when to seek human medical advice. Accuracy plus transparency is critical to building patient and provider trust.

The latest Apple Watch update will introduce a new feature that notifies users of potential high blood pressure, rather than providing continuous blood pressure readings. This strategic choice from Apple suggests that health wearables don't need to offer constant, highly technical readings to be useful. Smaller health wearable companies should take note: Doctors may not trust frequent wrist-based blood pressure data anyway. Instead of focusing on constant readings, the priority should be on developing features that provide meaningful, actionable insights for users and their doctors.